Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint Medical Dialogues Bureau24 Jan 2020 2:02 PM ISTUS: Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer...
Johnson and Johnson psoriasis drug gets expanded US approval for teens Ruby Khatun Khatun15 Oct 2017 9:47 AM ISTJohnson and Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients...